Frontal Fibrosing Alopecia: Literature Review of General, Pathophysiological, Diagnostic, and Treatment Aspects
 December 2024   
in “
 Brazilian Journal of Health Review 
”
 
    alopecia frontal fibrosante  scarring alopecia  frontotemporal hairline recession  eyebrow loss  immune factors  inflammatory factors  genetic factors  hormonal factors  environmental factors  autosomal dominant inheritance  local treatment  systemic treatment  surgical treatment  AFF  hairline recession  eyebrow thinning  immune response  inflammation  genetics  hormones  environmental influences  genetic inheritance  topical treatment  oral treatment  hair transplant   
    
   TLDR  Early diagnosis of alopecia frontal fibrosante is crucial, but treatment remains controversial and varies.   
  Alopecia frontal fibrosante (AFF) is a primary scarring alopecia characterized by the irreversible recession of the frontotemporal hairline and often results in eyebrow loss, predominantly affecting postmenopausal women around 60 years old. The pathophysiology of AFF is not well understood but is believed to involve immune, inflammatory, genetic, hormonal, and environmental factors, with a possible autosomal dominant inheritance pattern. Treatment options include local, systemic, or surgical approaches, but there is no standard treatment that effectively improves symptoms or stabilizes the condition universally, leading to controversies in treatment strategies. Early diagnosis is crucial to prevent disease progression and improve the quality of life for affected individuals. The article aims to clarify the general, pathophysiological, diagnostic, and therapeutic aspects of AFF.
    
   
   
   
   
  